26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

macrophage 472 macrophage<br />

INFγ<br />

Macrophage<br />

Fc receptor<br />

to circulatory embarrassment. Patients often develop skin<br />

hemorrhages, anemia, and neurological problems. This<br />

condition is considered less severe than multiple myeloma.<br />

macrophage<br />

A large mononuclear phagocytic cell found in many tissues.<br />

It is derived from monocytes in the blood and is active<br />

in innate immunity and early phases of nonadaptive host<br />

defense. It acts as a professional antigen-presenting cell and<br />

TNFα<br />

Reactive oxygen<br />

metabolites and<br />

lysosomal enzymes<br />

Tumor cell<br />

Epitope<br />

IgG antibody<br />

Tumor cell<br />

lysis<br />

Macrophage-mediated tumor cell lysis proceeds by several mechanisms. Activated macrophages express Fcγ receptors that anchor IgG molecules attached<br />

to tumor cells but not normal cells, resulting in the release of lysosomal enzymes and reactive oxygen metabolites and leading to tumor cell lysis. Another<br />

mechanism of macrophage-mediated lysis includes the release of tumor necrosis factor α (TNF-α) that may unite with its high affinity receptors on tumor<br />

cell surfaces, resulting in lysis, or exert its effects on small blood vessels and capillaries of vascularized tumors, leading to hemorrhagic necrosis, producing<br />

a localized Shwartzman-like reaction.<br />

INFγ<br />

Macrophage<br />

MHC class II<br />

receptor<br />

CD4+<br />

TCR<br />

Increase in<br />

MHC class II<br />

receptors<br />

Tumor cell<br />

epitope<br />

CD4 +<br />

helper<br />

T cell<br />

IL-2<br />

Cytotoxic<br />

T lymphocyte<br />

(CTL)<br />

T cell<br />

receptor<br />

CD8+<br />

MHC class I<br />

receptor<br />

Perforin and<br />

granzymes<br />

release<br />

Macrophage-mediated tumor immunity.<br />

Tumor cell<br />

Tumor cell<br />

lysis<br />

MCP-1 released by smooth muscle and endothelial cells promotes the recruitment of monocytes and macrophages to the subendothelial cell layer.<br />

Deposition of lipids within these monocytes and macrophages then leads to development of atherosclerotic lesions.<br />

an effector cell in both humoral and cell-mediated immunity.<br />

Interferon-γ (IFN-γ) activates macrophages to increase<br />

their capacity to kill intracellular microorganisms. IFN-γ<br />

activated and primed macrophages can engage in both antigen<br />

presentation and costimulation. A combination of IFN-γ<br />

and bacterial endotoxin may cause an activated macrophage<br />

to become hyperactivated, i.e., become a triggered cytolytic<br />

macrophage possessing increased activity against pathogens

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!